Holen Sie sich die Stockscreener-App
9.08
0.66%
0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAPR?
Forum
Prognose
Aktiensplit
Capricor Therapeutics Inc Aktie (CAPR) Neueste Nachrichten
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
CAPR Legal Notice: BFA Law Notifies Capricor Therapeutics Investors that Lost Money of the Imminent September 28 Securities Fraud Class Action Deadline - GlobeNewswire Inc.
Capricor Therapeutics, Inc. Notice of September 28, 2026 - GlobeNewswire
GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits
Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire
CAPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CAPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 28, 2026 DeadlineRGRD Law - marketscreener.com
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. - GlobeNewswire
CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT - GlobeNewswire
CAPR Lawsuit Alert: Capricor Therapeutics Investors Face September 28 Deadline After 64% Stock Drop Tied to Clinical Data Disclosure - PR Newswire
CAPR DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Datavault AI Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
CAPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ca - The National Law Review
Deadline Alert: Capricor Therapeutics, Inc. (CAPR) - GlobeNewswire
Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline - PR Newswire
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
CAPR FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionCAPR - ACCESS Newswire
2026-09-06 | CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:CAPR | Press Release - stockhouse.com
Bronstein, Gewirtz & Grossman LLC Urges Capricor - GlobeNewswire
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc.CAPR - PR Newswire
Could New Long-Term Data Support Capricor’s Duchenne Therapy? - Yahoo Finance
Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Leadership in a Securities Fraud Lawsuit by September 28, 2026 - Barchart.com
CAPR FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, - GlobeNewswire
CAPRCapricor Therapeutics Inc Options - Finviz
Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline - TMX Newsfile
Capricor Therapeutics (CAPR) Borrow Rates Rise Amidst Unprofitab - GuruFocus
CAPR Stock Drop: Capricor Therapeutics Faces Securities - globenewswire.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - ACCESS Newswire
Capricor: Downgrade to Hold On Deramiocel PDUFA Extension And DMD Change (NASDAQ:CAPR) - Seeking Alpha
CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action NoticeContact SueWallSt - morningstar.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesCAPR - PR Newswire
Kaplan Fox Deadline Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Have Until September 28, 2026 to Seek a Lead Plaintiff Role - The Globe and Mail
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 28, 2026 Deadline - PR Newswire
Capricor Therapeutics Shareholder Alert: ClaimsFiler - GlobeNewswire
Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)Lead Plaintiff Deadline is September 28, 2026 - Barchart.com
CAPR Stock Drop: Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Against Capricor Therapeutics, Inc. - The Globe and Mail
CAPR Deadline Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of Securities Class Action Deadline on September 28, 2026 - morningstar.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
$CAPR News: Capricor Therapeutics Sued for Securities Fraud - GlobeNewswire
Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026 - newmediawire.com
0.72%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):